Primary Job Title Executive Vice President, US Specialty Brands Primary Organization 
Mayne Pharma
Gender Male
Andy McClenaghan has more than 25 years’ of pharmaceutical industry experience across general management, marketing, sales, managed care, operations and regulatory affairs. Prior to leading Mayne Pharma’s new Specialty Brands Division in 2015, Andy was the Vice President of Commercial Operations for North America at Warner Chilcott and responsible
for US$2 billion in sales, a 700 member sales team and key brands including Doryx until its acquisition by Actavis in October 2013. He was also General Manager at Procter & Gamble Pharmaceuticals responsible for the Canadian business.
